Risk of Incident Type 2 Diabetes Following Anticonvulsant-Mood Stabilizer Treatment Initiation in Publicly Insured US Youth

被引：0
|
作者：
Burcu, Mehmet [1 ]
Zito, Julie M. [1 ]
Safer, Daniel J. [2 ]
机构：
[1] Univ Maryland Baltimore, Baltimore, MD USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
39
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [21] Patient-Reported Outcomes (PROs) during a Study of Feasibility of Continuous Glucose Monitor (CGM) Use in Publicly Insured Youth with Type 2 Diabetes (T2D)
    Tanenbaum, Molly L.
    Hanes, Sarah
    Hood, Korey K.
    Maahs, David M.
    Shah, Sejal
    DIABETES, 2023, 72
  • [22] Association between Protein Intake and Diabetes Complications Risk Following Incident Type 2 Diabetes: The EPIC-Potsdam Study
    Inan-Eroglu, Elif
    Kuxhaus, Olga
    Jannasch, Franziska
    Nickel, Daniela V.
    Schulze, Matthias B.
    METABOLITES, 2024, 14 (03)
  • [23] Glycaemic outcomes following initiation of insulin glargine or exenatide in type 2 diabetes patients treated with oral agents in US
    Bhushan, R.
    Rosenstock, J.
    Dain, M. -P.
    Bhushan, M.
    Home, P.
    DIABETOLOGIA, 2009, 52 : S293 - S293
  • [24] Incident Heart Failure Hospitalization Risk Associated with DPP-4 inhibitors Use in Type 2 Diabetes Following Metformin Treatment - A Novel Approach
    Chang, Chia-Hsuin
    Dong, Yaa-Hui
    Wu, Li-Chiu
    Hwang, Jing-Shiang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 181 - 182
  • [25] ASSESSMENT OF THE HIGH RISK AND UNMET NEED IN PATIENTS WITH CAD AND TYPE 2 DIABETES (ATHENA): US BURDEN OF ILLNESS IN A COMMERCIALLY-INSURED POPULATION
    Wittbrodt, Eric
    Bhalla, Narinder
    Sundell, Karolina Andersson
    Hunt, Phillip
    Rudnik, Janek
    Wong, Nathan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 38 - 38
  • [26] BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study
    Elli Polemiti
    Julia Baudry
    Olga Kuxhaus
    Susanne Jäger
    Manuela M. Bergmann
    Cornelia Weikert
    Matthias B. Schulze
    Diabetologia, 2021, 64 : 814 - 825
  • [27] The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid-related and phenotypic groups
    Ambery, Philip
    Adamsson Eryd, Samuel
    Jenkins-Jones, Sara
    Heywood, Ben
    Berni, Ellen
    Brown, Mary N.
    Astbury, Carol
    Hunt, Phillip
    Currie, Craig J.
    DIABETES OBESITY & METABOLISM, 2022, 24 (11): : 2222 - 2231
  • [28] BMI and BMI change following incident type 2 diabetes and risk of microvascular andmacrovascular complications: the EPIC-Potsdam study
    Polemiti, E.
    Baudry, J.
    Kuxhaus, O.
    Jaeger, S.
    Bergmann, M. M.
    Weikert, C.
    Schulze, M. B.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S142 - S142
  • [29] BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study
    Polemiti, Elli
    Baudry, Julia
    Kuxhaus, Olga
    Jaeger, Susanne
    Bergmann, Manuela M.
    Weikert, Cornelia
    Schulze, Matthias B.
    DIABETOLOGIA, 2021, 64 (04) : 814 - 825
  • [30] Vascular Protection with ACE Inhibitors or Angiotensin II Receptor Antagonists Following Type 2 Diabetes Treatment Initiation in Elderly
    Guenette, Line
    Breton, Marie-Claude
    Gregoire, Jean-Pierre
    Moisan, Jocelyne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 67 - 67
12345